WO2024157173 - COMPOSITION AND A PHOTODYNAMIC THERAPEUTIC METHOD TO SHORTEN INFECTIVITY PERIOD AND TO INDUCE SUSTAINED HUMORAL AND CELLULAR T-CELL RESPONSES AGAINST A TARGETED ANTIGEN IN INFECTED INDIVIDUALS
National phase entry is expected:
Publication Number
WO/2024/157173
Publication Date
02.08.2024
International Application No.
PCT/IB2024/050638
International Filing Date
23.01.2024
Title **
[English]
COMPOSITION AND A PHOTODYNAMIC THERAPEUTIC METHOD TO SHORTEN INFECTIVITY PERIOD AND TO INDUCE SUSTAINED HUMORAL AND CELLULAR T-CELL RESPONSES AGAINST A TARGETED ANTIGEN IN INFECTED INDIVIDUALS
[French]
COMPOSITION ET PROCÉDÉ THÉRAPEUTIQUE PHOTODYNAMIQUE POUR RACCOURCIR LA PÉRIODE D'INFECTIOSITÉ ET POUR INDUIRE DES RÉPONSES DE LYMPHOCYTES T HUMORAUX ET CELLULAIRES SOUTENUES CONTRE UN ANTIGÈNE CIBLÉ CHEZ DES INDIVIDUS INFECTÉS
Applicants **
ONDINE INTERNATIONAL AG
c/o Confidaris AG
Oberwiller Kirchweg 4A
6300 Zug, CH
Inventors
LOEBEL, Nicolas
15211 NE 167th Pl.
Woodinville, Washington 98072, US
FERNANDEZ-MONTERO, Alejandro
Isabel Garbayo Ayala 9, port. 4, 7A.
31008 Pamplona Navarra, ES
BALLBE, José Maria Argemi
Av. Pio XII, 35, 9-C
31008 Pamplona Navarra, ES
CROSS, Carolyn
888-1100 Melville St.
Vancouver, British Columbia V6E4A6, CA
Priority Data
63/441,125
25.01.2023
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1131 | |
| EPO | Filing, Examination | 4626 | |
| Japan | Filing | 590 | |
| South Korea | Filing | 575 | |
| USA | Filing, Examination | 2710 |
Total: 9632 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention provides a photodynamic therapeutic method to shorten the infectivity period of an infection caused by a targeted microorganism comprising: applying a photosensitizer on a targeted body treatment area; and applying light to the targeted body treatment area at a wavelength absorbed by the photosensitizer. The present invention also provides a method to induce a sustained humoral and cellular T-Cell responses against an antigen of a targeted microorganism comprising: applying a photosensitizer on a targeted body treatment area; and applying light to the targeted body treatment area at a wavelength absorbed by the photosensitizer.[French]
La présente invention concerne un procédé thérapeutique photodynamique pour raccourcir la période d'infectiosité d'une infection provoquée par un micro-organisme ciblé comprenant : l'application d'un photosensibilisateur sur une zone de traitement de corps ciblée ; et l'application de lumière à la zone de traitement de corps ciblée à une longueur d'onde absorbée par le photosensibilisateur. La présente invention concerne également un procédé pour induire des réponses de lymphocytes T humoraux et cellulaires soutenues contre un antigène d'un micro-organisme ciblé comprenant : l'application d'un photosensibilisateur sur une zone de traitement de corps ciblée ; et l'application de lumière à la zone de traitement de corps ciblée à une longueur d'onde absorbée par le photosensibilisateur.